BCG-COVID-RCT: BCG vaccine to reduce absenteeism due to infectious diseases of health workers during the COVID-19 pandemic. A multi-centre randomised controlled trial
- Funded by European & Developing Countries Clinical Trials Partnership (EDCTP)
- Total publications:7 publications
Grant number: RIA2020EF-3049
Grant search
Key facts
Disease
COVID-19start year
2020Known Financial Commitments (USD)
$583,727.12Funder
European & Developing Countries Clinical Trials Partnership (EDCTP)Principal Investigator
Prof. Christine Stabell-BennResearch Location
Guinea-Bissau, Cabo VerdeLead Research Institution
University of Southern DenmarkResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measures
Research Subcategory
Economic impacts
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Randomized Controlled Trial
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The BCG-COVID-RCT project (RIA2020EF-3049) aims to study the BCG non-specific protection of healthcare workers against COVID-19.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC